Immunomedics Inc 's ability to collect accounts receivable sequentially worsen to 3.61, indicating more challenging environment then in the first quarter 2020, but still, it is a far cry from any concerns. Immunomedics Inc 's Accounts Receivable average collection period in the Jun 30 2020 quarter, has increased to 101 days, from 91 days, in the Mar 31 2020 quarter.

If we take a look into Healthcare sector Immunomedics Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Immunomedics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

IMMU Receivables Turnover Ratio	(Jun 30 2020) II. Quarter	(Mar 31 2020) I. Quarter	(Dec 31 2019) IV. Quarter	(Sep 30 2019) III. Quarter	(Jun 30 2019) II. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	-	-	-72.6 %	-	-
Receivable Turnover Ratio (TTM)	3.61	4	4	-	-
IMMU's Total Ranking	#	#	#	#	#
Accounts Receivable average collection period days	101	91	91	-	-
Seq. Receivable Change	-	-	-	-	-
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
In Vitro & In Vivo Diagnostic Substances Industry	#
Healthcare Sector	#
Overall Market	#

Receivable Turnover Ratio Statistics
High	Average	Low
0	0	0

IMMU Company Profile • Back to IMMU Efficiency Comparisons • Compare IMMU Receivables Turnover Ratio to its Competitors

Financial Statements
Immunomedics Inc 's Accounts Receivable	$ 22 Millions	Visit IMMU's Balance sheet
Immunomedics Inc 's Sales TTM	$ 20 Millions	Visit IMMU's Income Statement
Sources of IMMU's Revenues		Visit IMMU's Sales by Geography

Other Accounts Receivable Turnover Ratios
In Vitro & In Vivo Diagnostic Substances Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
IMMU's Receivable Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
IMMU's Growth Rates	IMMU's Roa	IMMU's Inventory Turnover Ratio	IMMU's Dividend Comparisons
IMMU's Profitability Ratios	IMMU's Roi	IMMU's Asset Turnover Ratio	IMMU's Dividend Growth
IMMU's Valuation Ratios	IMMU's Roe	IMMU's Financial Strength Ratios	IMMU's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2020, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2020	Receivable at quarter ending Jun 30 2020
Viewray Inc	2.52	$ 65.805 Millions	$ 26.149 Millions
Interpace Biosciences Inc	2.51	$ 26.445 Millions	$ 10.519 Millions
Electromed Inc	2.48	$ 32.471 Millions	$ 13.108 Millions
Bionik Laboratories Corp	2.42	$ 1.621 Millions	$ 0.669 Millions
Sangui Biotech International Inc	2.41	$ 0.029 Millions	$ 0.012 Millions
Spero Therapeutics Inc	2.40	$ 11.701 Millions	$ 4.883 Millions
American Shared Hospital Services	2.39	$ 15.362 Millions	$ 6.432 Millions
Envista Holdings Corporation	2.31	$ 909.200 Millions	$ 393.075 Millions
Apyx Medical Corp	2.30	$ 25.137 Millions	$ 10.948 Millions
Statera Biopharma Inc fka Cytocom Inc	2.28	$ 0.667 Millions	$ 0.293 Millions
Castle Biosciences Inc	2.23	$ 30.133 Millions	$ 13.536 Millions
Cytomx Therapeutics Inc	2.18	$ 85.192 Millions	$ 39.090 Millions
Eyepoint Inc	2.17	$ 22.754 Millions	$ 10.491 Millions
Biospecifics Technologies Corp	2.10	$ 34.778 Millions	$ 16.571 Millions
Aerie Pharmaceuticals Inc	2.07	$ 81.575 Millions	$ 39.413 Millions
Adaptive Biotechnologies Corporation	1.98	$ 19.463 Millions	$ 9.807 Millions
Nabriva Therapeutics Plc	1.98	$ 8.529 Millions	$ 4.299 Millions
Rennova Health Inc	1.93	$ 9.527 Millions	$ 4.939 Millions
Biora Therapeutics Inc	1.91	$ 17.901 Millions	$ 9.355 Millions
Xeris Biopharma Holdings Inc	1.91	$ 6.498 Millions	$ 3.411 Millions
Sensus Healthcare Inc	1.89	$ 17.213 Millions	$ 9.108 Millions
Biocept Inc	1.75	$ 5.677 Millions	$ 3.247 Millions
Bionano Genomics Inc	1.71	$ 8.420 Millions	$ 4.925 Millions
Regenxbio Inc	1.68	$ 60.678 Millions	$ 36.180 Millions
Establishment Labs Holdings Inc	1.67	$ 34.955 Millions	$ 20.887 Millions
American Cryostem Corporation	1.65	$ 0.582 Millions	$ 0.352 Millions
Dicerna Pharmaceuticals Inc	1.64	$ 89.591 Millions	$ 54.603 Millions
Biocardia Inc	1.63	$ 0.473 Millions	$ 0.291 Millions
Dyadic International Inc	1.59	$ 1.727 Millions	$ 1.085 Millions
Lexaria Bioscience Corp	1.52	$ 0.391 Millions	$ 0.257 Millions

Date modified: 2026-08-29T17:15:09+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.